Kumar, A. (2012). Second line therapy: Type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: For GLP-1/DPP-IV inhibitors. Diabetes/metabolism research and reviews, 28(s2), 21-25. https://doi.org/10.1002/dmrr.2350
Chicago Style (17th ed.) CitationKumar, Ajay. "Second Line Therapy: Type 2 Diabetic Subjects Failing on Metformin GLP-1/DPP-IV Inhibitors Versus Sulphonylurea/insulin: For GLP-1/DPP-IV Inhibitors." Diabetes/metabolism Research and Reviews 28, no. s2 (2012): 21-25. https://doi.org/10.1002/dmrr.2350.
MLA (9th ed.) CitationKumar, Ajay. "Second Line Therapy: Type 2 Diabetic Subjects Failing on Metformin GLP-1/DPP-IV Inhibitors Versus Sulphonylurea/insulin: For GLP-1/DPP-IV Inhibitors." Diabetes/metabolism Research and Reviews, vol. 28, no. s2, 2012, pp. 21-25, https://doi.org/10.1002/dmrr.2350.